红细胞输血的模式和结果在接受皮肤冠状动脉干预的患者中
Matthew W Sherwood1, Yongfei Wang2, Jeptha P Curtis2
1Duke Clinical Research Institute, Durham, North Carolina.
JAMA
|February 27, 2014
概括
在接受皮肤冠状动脉干预 (PCI) 的患者中,红细胞输血在美国医院之间有显著的差异. 输血与心脏不良事件的风险更高有关,这表明需要进一步研究最佳输血策略.
科学领域:
- 心脏病学 心脏病学
- 输血医学 输血医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 红细胞输血实践在急性冠状动脉综合征患者之间存在很大差异.
- 在接受皮肤冠状动脉干预 (PCI) 的患者中,对输血的疗效和潜在危害的数据有限.
- 目前PCI患者的输血模式尚不清楚.
研究的目的:
- 为了检查在美国医院接受PCI的患者当前的输血模式.
- 在这个患者群体中调查输血与心脏不良结果之间的关联.
主要方法:
- 使用CathPCI注册表数据进行的回顾性队列研究 (2009年7月 - 2013年3月).
- 包括超过220万名涉及PCI的患者访问,不包括那些缺乏出血数据或接受冠状动脉旁路移植手术的患者.
- 分析了输血率及其与心肌梗塞,中风和死亡的相关性,并根据患者对输血的倾向进行调整.
主要成果:
- 整体输血率为2.14%,在研究期间观察到略有下降.
- 即使在风险调整后,输血率在医院一级的显著变化仍然存在.
- 输血与心肌梗塞 (OR 2.60),中风 (OR 7.72) 和住院死亡 (OR 4.63) 的几率增加有关,而不考虑出血并发症.
结论:
- 在美国,接受PCI的患者的输血实践存在相当大的差异.
- 接受输血与在医院内发生不良心脏事件的风险更高有关.
- 这些发现支持需要随机试验来评估PCI患者的输血策略.
更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
4.0K
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
4.9K
相关概念视频
Blood Transfusion
3.0K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
3.0K
Cardiac Catheterization I: Pre-Procedure Overview
3.4K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Blood Transfusion and Agglutination
13.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.0K
